Clinical Trials
156 trialsStudy of Sonodynamic Therapy in Participants With Recurrent High-Grade Glioma
St. Joseph's Hospital and Medical Center, Phoenix
Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
St. Joseph's Hospital and Medical Center, Phoenix
ACTION
University of Florida
SOPHNEURO
Institut Cancerologie de l'Ouest
A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations
Hutchmed
A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab
University of Wisconsin, Madison
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases
Wake Forest University Health Sciences
Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse
Exelixis
Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)
University of Alabama at Birmingham
FIGHT-209
Incyte Corporation
NeoGlio
Geisinger Clinic
Infigratinib in Recurrent High-Grade Glioma Patients
St. Joseph's Hospital and Medical Center, Phoenix
JAZZ
Wake Forest University Health Sciences
Study of Stored Tumor Samples in Young Patients With Brain Tumors
St. Jude Children's Research Hospital
Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors
Novartis
Study of IK-595 in RAS- or RAF-altered Advanced Tumors
Ikena Oncology
STAR-3
Kintara Therapeutics, Inc.
A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG
Alaunos Therapeutics
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
National Institutes of Health Clinical Center (CC)
PEAR-GLIO
Ourotech, Inc.
ONC201 in Adults With Recurrent H3 K27M-mutant Glioma
Jazz Pharmaceuticals
OU-SCC-PI-4G
University of Oklahoma
Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors
Thomas Jefferson University
SEL-TH-1601
Children's Hospital Medical Center, Cincinnati
REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
Regeneron Pharmaceuticals
Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas
Dawonmedax Co., Ltd.
ONC201 in Pediatric H3 K27M Gliomas
Jazz Pharmaceuticals
SURF-ROGG
University Hospital Schleswig-Holstein
Oral AMXT 1501 Dicaprate in Combination With IV DFMO
Aminex Therapeutics, Inc.
ETERNITI
Bexion Pharmaceuticals, Inc.
KONQUER
Bexion Pharmaceuticals, Inc.
GBMdexaB
Amsterdam UMC, location VUmc
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
Washington University School of Medicine
BRAF
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma
Amgen
Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water
University of Utah
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
University of California, San Francisco
Identification of Genomic Changes in Families Having Multiple Members With Tumors
St. Joseph's Hospital and Medical Center, Phoenix
EDGE
University of Oxford
AsiDNA
Institut Curie
Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
University of Nebraska
Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
University of Nebraska
Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
OncoSynergy, Inc.
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
Nuvation Bio Inc.
Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
Mayo Clinic
Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma
H. Lee Moffitt Cancer Center and Research Institute
ECoG
Ramsay Générale de Santé